GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (FRA:YB3) » Definitions » DeferredTaxAndRevenue

Shin Nippon Biomedical Laboratories (FRA:YB3) DeferredTaxAndRevenue : €0.0 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Shin Nippon Biomedical Laboratories's current deferred tax and revenue for the quarter that ended in Dec. 2023 was €0.0 Mil.

Shin Nippon Biomedical Laboratories DeferredTaxAndRevenue Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories DeferredTaxAndRevenue Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shin Nippon Biomedical Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shin Nippon Biomedical Laboratories DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shin Nippon Biomedical Laboratories (FRA:YB3) Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (FRA:YB3) Headlines

No Headlines